← Leaderboards
Chuanhai Cao
University Of South Florida
$1,582,709
Attributed
$3,165,418
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $580.5K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,165,418 · 1
By mechanism
R01$3,165,418 · 1
Top collaborators
- Jianfeng Cai7 shared
Most similar at University Of South Florida
Same institution · by research overlap
- Jianfeng Cai$10,262,045
- Gary W Arendash$2,217,835
- David Morgan$15,699,395
- Ghanim Ullah$1,549,414
- Tian Liu$1,981,704
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposFunctional GroupAlpha SynucleinHuntington DiseaseEnzyme Inhibitor DrugsExcisionCytotoxicityDementiaDiabetes MellitusDisorder PreventionAbeta AccumulationAmyloidosisAmyloid ProteinsEtiologyDepositionAbeta OligomerInnovationBindingBiocompatible MaterialsAlzheimerâS Disease BiomarkerDesignCellsAmyloid Beta-ProteinInsight
Grant awards (7)
Recognition of Abeta monomeric helix$568,883
R01 · FY2025 · AG
Recognition of Abeta monomeric helix$580,493
R01 · FY2024 · AG
Recognition of Abeta monomeric helix$579,848
R01 · FY2023 · AG
Gamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation$355,839
R01 · FY2021 · AG
Gamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation$358,175
R01 · FY2020 · AG
Gamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation$360,207
R01 · FY2019 · AG
Gamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation$361,973
R01 · FY2018 · AG